Table 1.
Patient characteristics and sequencing data.
| Characteristics | Acral (n = 104) | Sun-exposed (n = 157) |
|---|---|---|
| Age (years) | ||
| Median (range) | 62 (29–89) | 66 (20–94) |
| Sex, n (%) | ||
| Female | 42 (40) | 61 (39) |
| Male | 62 (60) | 96 (61) |
| Stage at tumor resection, n (%) | ||
| 0 | 1 (1) | 0 (0) |
| 1 | 10 (10) | 7 (4) |
| 2 | 39 (38) | 22 (14) |
| 3 | 28 (27) | 7 (4) |
| 4 | 26 (25) | 121 (77) |
| Tumor sample site, n (%) | ||
| Primary | 81 (78) | 41 (26) |
| Metastatic | 23 (22) | 116 (74) |
| WES, n (%) | ||
| Yale University | 32 (33) | 134 (100) |
| Central South University | 65 (67) | 0 (0) |
| Bulk RNA-seq, total n (n with WES) | ||
| Yale University | 22 (17) | 60 (37) |
| Central South University | 23 (21) | 0 |
Of 104 tumor specimens from patients with acral melanoma, 97 were profiled by WES, 7 were profiled by bulk RNA-seq and not WES, and 45 were profiled by both. Of 157 tumor specimens from patients with sun-exposed melanoma, 134 were profiled by WES, 23 were profiled by bulk RNA-seq and not WES, and 37 were profiled by both.